Vishal Navani

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Current oncology (Toronto, Ont.)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of clinical pharmacology

Endocrinology, diabetes & metabolism case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Amanda Jane Williams Gibson, Michelle Liane Dean, Ishjot Litt, Adrian Box, Winson Y Cheung, Vishal Navani
Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for EGFR Mutation-Positive Patients Treated with First-Line Osimertinib. Current oncology (Toronto, Ont.) 31 (5) (2024)
Amanda Jane Williams Gibson, Michelle Liane Dean, Ishjot Litt, Adrian Box, Winson Y Cheung, Vishal Navani
Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for EGFR Mutation-Positive Patients Treated with First-Line Osimertinib. Current oncology (Toronto, Ont.) 31 (5) (2024)
Abhenil Mittal, Sara Moore, Vishal Navani, Di Maria Jiang, David J Stewart, Geoffrey Liu, Paul Wheatley-Price
What Is Ailing Oncology Clinical Trials? Can We Fix Them? Current oncology (Toronto, Ont.) 31 (7) (2024)
David J Stewart, John-Peter Bradford, Sandeep R Sehdev, Tim Ramsay, Vishal Navani, Nigel S B Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan G Kaplan, Silvana Spadafora, Shaun G Goodman, Rebecca A C Auer, Gerald Batist
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices. Current oncology (Toronto, Ont.) 31 (5) (2024)
Abhenil Mittal, Sara Moore, Vishal Navani, Di Maria Jiang, David J Stewart, Geoffrey Liu, Paul Wheatley-Price
What Is Ailing Oncology Clinical Trials? Can We Fix Them? Current oncology (Toronto, Ont.) 31 (7) (2024)
Amanda Jane Williams Gibson, Michelle Liane Dean, Ishjot Litt, Adrian Box, Winson Y Cheung, Vishal Navani
Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for EGFR Mutation-Positive Patients Treated with First-Line Osimertinib. Current oncology (Toronto, Ont.) 31 (5) (2024)
David J Stewart, Timothy Ramsay, Vishal Navani, Geoffrey Liu, Di Maria Jiang, Gerald Batist
Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2024)
David J Stewart, John-Peter Bradford, Sandeep R Sehdev, Tim Ramsay, Vishal Navani, Nigel S B Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan G Kaplan, Silvana Spadafora, Shaun G Goodman, Rebecca A C Auer, Gerald Batist
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices. Current oncology (Toronto, Ont.) 31 (5) (2024)
Abhenil Mittal, Sara Moore, Vishal Navani, Di Maria Jiang, David J Stewart, Geoffrey Liu, Paul Wheatley-Price
What Is Ailing Oncology Clinical Trials? Can We Fix Them? Current oncology (Toronto, Ont.) 31 (7) (2024)
David J Stewart, John-Peter Bradford, Sandeep R Sehdev, Tim Ramsay, Vishal Navani, Nigel S B Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan G Kaplan, Silvana Spadafora, Shaun G Goodman, Rebecca A C Auer, Gerald Batist
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices. Current oncology (Toronto, Ont.) 31 (5) (2024)
David J Stewart, Timothy Ramsay, Vishal Navani, Geoffrey Liu, Di Maria Jiang, Gerald Batist
Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2024)
David J Stewart, Timothy Ramsay, Vishal Navani, Geoffrey Liu, Di Maria Jiang, Gerald Batist
Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Igor Stukalin, Vishal Navani, Mehul Gupta, Yibing Ruan, Devon J Boyne, Dylan E O'Sullivan, Daniel E Meyers, Siddhartha Goutam, Michael Sander, Benjamin W Ewanchuk, Darren R Brenner, Aleksi Suo, Winson Y Cheung, Daniel Y C Heng, Jose G Monzon, Tina Cheng
Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. The oncologist (2023)
Vishal Navani, Moira C Graves, Giovana Celli Marchett, Hiren Mandaliya, Nikola A Bowden, Andre van der Westhuizen
Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers. Pharmacology research & perspectives 9 (4) (2022)
Vishal Navani, James F Lynam, Steven Smith, Christine J O'Neill, Christopher W Rowe
Castration failure in prostate carcinoma due to a functioning adrenocortical carcinoma. Endocrinology, diabetes & metabolism case reports 2021 (2021)
Vishal Navani, Moira C Graves, Nikola A Bowden, Andre Van Der Westhuizen
Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response. British journal of clinical pharmacology 86 (9) (2020)